Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Corsica Health vs PrescribedRX

Corsica Health
Graded #188

Higher grade

vs+7.299999999999997
PrescribedRX
Graded #351

Lower grade

The verdict

Corsica Health takes it — 66.3/100 to 59/100.

Corsica Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Corsica Health is a telehealth platform offering both compounded GLP-1s and brand-name FDA-approved injections through a structured assessment, provider review, and medication flow.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCorsica Health +1
48
47
Dose & formulationEven
77
77
Clinical oversightCorsica Health +13
87
74
Labs & monitoringCorsica Health +2
54
52
FulfillmentCorsica Health +11
75
64
Contract termsCorsica Health +35
55
20
Corsica Health · left barPrescribedRX · right bar

The numbers

MetricCorsica HealthPrescribedRX
WeighScore66.3/10059/100
GradeCC
Scorecard rank#188#351
Semaglutide$249/mo (compounded)$189/mo (compounded)
Tirzepatide$349/mo (compounded)$276/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Corsica Health

Graded #188 · C

Strengths

  • Public pricing shown for both compounded and brand-name options — a real transparency advantage
  • $1,499/mo brand-name Wegovy/Ozempic/Mounjaro is below typical retail cash-pay
  • LegitScript Certified
  • Clear 3-step intake: Assessment, Provider Review, Receive Medication
  • $199/mo compounded semaglutide and $249/mo compounded tirzepatide (3-month plans) are competitively priced

Where it loses points

  • Legal entity name and state of incorporation not disclosed on the site
  • Pharmacy partner described only as a 'licensed compounding pharmacy,' not named
  • Per-state availability not listed publicly
  • First-month promotional pricing not disclosed
  • Lab-work inclusion not clearly disclosed
PrescribedRX

Graded #351 · C

Strengths

  • Compounded semaglutide ($189/mo) and tirzepatide ($276/mo) injectables, with lower per-month pricing on the 3-month plans ($176 and $233/mo)
  • Clear, upfront plan pages showing monthly and multi-month pricing with no surprise fees
  • Care from licensed US providers with monthly home delivery and ongoing dose support
  • Bilingual English/Spanish site and a broader telehealth menu (TRT, longevity, hair, sexual health) for people who want more than weight loss

Where it loses points

  • Doesn't publish the states it serves — you only learn eligibility after starting the intake
  • Compounding pharmacies aren't named on the site
  • Mid-range pricing — cheaper compounded GLP-1 options exist and the 3-month discount is modest
  • Compounded semaglutide and tirzepatide injectables only — no brand-name or oral options
  • Self-hosted affiliate program (not a vetted network); Florida/Palm Beach framing suggests a regional lean

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard